• RCCSE中国核心学术期刊(A+)
  • 中国百强报刊
  • 百种中国杰出学术期刊
  • 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国自然科学类核心期刊
  • 中国科技论文统计源期刊
  • 中华医学会优秀期刊
  • 中国精品科技期刊顶尖学术论文(5000)项目来源期刊
  • 入选中国高质量科技期刊分级目录(消化病学)T1级
  • 入选《中国学术期刊影响因子年报(自然科学与工程技术)》Q1区
  • 入选《科技期刊世界影响力指数(WJCI)报告(2022)》
  • RCCSE中国核心学术期刊(A+)
  • 中国百强报刊
  • 百种中国杰出学术期刊
  • 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国自然科学类核心期刊
  • 中国科技论文统计源期刊
  • 中华医学会优秀期刊
  • 中国精品科技期刊顶尖学术论文(5000)项目来源期刊
  • 入选中国高质量科技期刊分级目录(消化病学)T1级
  • 入选《中国学术期刊影响因子年报(自然科学与工程技术)》Q1区
  • 入选《科技期刊世界影响力指数(WJCI)报告(2022)》
Epidemiological characteristics, diagnosis, treatment and prognosis of gallbladder cancer in China: a report of 6 159 cases[J]. Chinese Journal of Digestive Surgery, 2022, 21(1): 114-128. DOI: 10.3760/cma.j.cn115610-20220103-00004
Citation: Epidemiological characteristics, diagnosis, treatment and prognosis of gallbladder cancer in China: a report of 6 159 cases[J]. Chinese Journal of Digestive Surgery, 2022, 21(1): 114-128. DOI: 10.3760/cma.j.cn115610-20220103-00004

Epidemiological characteristics, diagnosis, treatment and prognosis of gallbladder cancer in China: a report of 6 159 cases

More Information
  • Objective To investigate the epidemiological characteristics, diagnosis, treatment and prognosis of gallbladder cancer in China from 2010 to 2017. Methods The single disease retrospective registration cohort study was conducted. Based on the concept of the real world study, the clinicopathological data, from multicenter retrospective clinical data database of gallbladder cancer of Chinese Research Group of Gallbladder Cancer (CRGGC), of 6 159 patients with gallbladder cancer who were admitted to 42 hospitals from January 2010 to December 2017 were collected.Observation indicators: (1) case resources; (2) age and sex distribution; (3) diagnosis; (4) surgical treatment and prognosis; (5) multimodality therapy and prognosis. The follow-up data of the 42 hospitals were collected and analyzed by the CRGGC. The main outcome indicator was the overall survival time from date of operation for surgical patients or date of diagnosis for non-surgical patients to the end of outcome event or the last follow-up. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was conducted using the t test. Measurement data with skewed distribution were represented as M(Q1,Q3) or M(range), and comparison between groups was conducted using the U test. Count data were described as absolute numbers or percentages, and comparison between groups was conducted using the chi-square test. Univariate analysis was performed using the Logistic forced regression model, and variables with P< 0.1 in the univariate analysis were included for multivariate analysis. Multivariate analysis was performed using the Logistic stepwise regression model. The life table method was used to calculate survival rates and the Kaplan-Meier method was used to draw survival curves. Log-rank test was used for survival analysis. Results (1) Case resources: of the 42 hospitals, there were 35 class A of  tertiary hospitals and 7 class B of tertiary hospitals, 16 hospitals with high admission of gallbladder cancer and 26 hospitals with low admission of gallbladder cancer, respectively. Geographical distribution of the 42 hospitals: there were 9 hospitals in central China, 5 hospitals in northeast China, 22 hospitals in eastern China and 6 hospitals in western China. Geographical distribution of the 6 159 patients: there were 2 154 cases(34.973%) from central China, 705 cases(11.447%) from northeast China, 1 969 cases(31.969%) from eastern China and 1 331 cases(21.611%) from western China. The total average number of cases undergoing diagnosis and treatment in hospitals of the 6 159 patients was 18.3±4.5 per year, in which the average number of cases undergoing diagnosis and treatment in hospitals of 4 974 patients(80.760%) from hospitals with high admission of gallbladder cancer was 38.8±8.9 per year and the average number of cases undergoing diagnosis and treatment in hospitals of 1 185 patients(19.240%) from hospitals with low admission of gallbladder cancer was 5.7±1.9 per year. (2) Age and sex distribution: the age of 6 159 patients diagnosed as gallbladder cancer was 64(56, 71) years, in which the age of 2 247 male patients(36.483%) diagnosed as gallbladder cancer was 64(58,71)years and the age of 3 912 female patients(63.517%) diagnosed as gallbladder cancer was 63(55,71)years. The sex ratio of female to male was 1.74:1. Of 6 159 patients, 3 886 cases(63.095%) were diagnosed as gallbladder cancer at 56 to 75 years old. There was a significant difference on age at diagnosis between male and female patients (Z=?3.99, P< 0.001). (3) Diagnosis: of 6 159 patients, 2 503 cases(40.640%) were initially diagnosed as gallbladder cancer and 3 656 cases(59.360%) were initially diagnosed as non-gallbladder cancer. There were 2 110 patients(34.259%) not undergoing surgical treatment, of which 200 cases(9.479%) were initially diagnosed as gallbladder cancer and 1 910 cases(90.521%) were initially diagnosed as nongallbladder cancer. There were 4 049 patients(65.741%) undergoing surgical treatment, of which 2 303 cases(56.878%) were initially diagnosed as gallbladder cancer and 1 746 cases(43.122%) were initial diagnosed as non-gallbladder cancer. Of the 1 746 patients who were initially diagnosed as nongallbladder cancer, there were 774 cases(19.116%) diagnosed as gallbladder cancer during operation and 972 cases(24.006%) diagnosed as gallbladder cancer after operation. Of 6 159 patients, there were 2 521 cases(40.932%), 2 335 cases(37.912%) and 1 114 cases(18.087%) undergoing ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) examination before initial diagnosis, respec-tively, and there were 3 259 cases(52.914%), 3 172 cases(51.502%) and 4 016 cases(65.205%) undergoing serum carcinoembryonic antigen, CA19-9 or CA125 examination before initially diagnosis, respectively. One patient may underwent multiple examinations. Results of univariate analysis showed that geographical distribution of hospitals (eastern China or western China), age ≥72 years, gallbladder cancer annual admission of hospitals, whether undergoing ultrasound, CT, MRI, serum carcinoembryonic antigen, CA19-9 or CA125 examination before initially diagnosis were related factors influencing initial diagnosis of gallbladder cancer patients (odds ratio= 1.45, 1.98, 0.69, 0.68, 2.43, 0.41, 1.63, 0.41, 0.39, 0.42, 95% confidence interval as 1.21?1.74, 1.64? 2.40, 0.59?0.80, 0.60?0.78, 2.19?2.70, 0.37?0.45, 1.43?1.86, 0.37?0.45, 0.35?0.43, 0.38?0.47, P< 0.05). Results of multivariate analysis showed that geographical distribution of hospitals (eastern China or western China), sex, age ≥72 years, gallbladder cancer annual admission of hospitals and cases undergoing ultrasound, CT, serum CA19-9 examination before initially diagnosis were independent influencing factors influencing initial diagnosis of gallbladder cancer patients (odds ratio=1.36, 1.42, 0.89, 0.67, 1.85, 1.56, 1.57, 0.39, 95% confidence interval as 1.13?1.64, 1.16?1.73, 0.79?0.99,0.57?0.78, 1.60?2.14, 1.38?1.77, 1.38?1.79, 0.35?0.43, P<0.05). (4) Surgical treatment and prognosis. Of the 4 049 patients undergoing surgical treatment, there were 2 447 cases(60.435%) with complete pathological staging data and follow-up data. Cases with pathological staging as stage 0, stage Ⅰ, stage Ⅱ, stage Ⅲa, stage Ⅲb, stage Ⅳa and stage Ⅳb were 85(3.474%), 201(8.214%), 71(2.902%), 890(36.371%), 382(15.611%), 33(1.348%) and 785(32.080%), respectively. The median follow-up time and median postoperative overall survival time of the 2 447 cases were 55.75 months (95% confidence interval as 52.78 ? 58.35) and 23.46 months (95% confidence interval as 21.23 ? 25.71), respectively. There was a significant difference in the overall survival between cases with pathological staging as stage 0, stage Ⅰ, stage Ⅱ, stage Ⅲa, stage Ⅲb, stage Ⅳa and stage Ⅳb (χ 2 =512.47, P<0.001). Of the 4 049 patients undergoing surgical treatment, there were 2 988 cases(73.796%) with resectable tumor, 177 cases(4.371%) with unresectable tumor and 884 cases(21.833%) with tumor unassessable for resectabi-lity. Of the 2 988 cases with resectable tumor, there were 2 036 cases (68.139%) undergoing radical resection, 504 cases(16.867%) undergoing non-radical resection and 448 cases(14.994%) with operation unassessable for curative effect. Of the 2 447 cases with complete pathological staging data and follow-up data who underwent surgical treatment, there were 53 cases(2.166%) with unresectable tumor, 300 cases(12.260%) with resectable tumor and receiving non-radical resection, 1 441 cases(58.888%) with resectable tumor and receiving radical resection, 653 cases(26.686%) with resectable tumor and receiving operation unassessable for curative effect. There were 733 cases not undergoing surgical treatment with complete pathological staging data and follow-up data. There was a significant difference in the overall survival between cases not undergoing surgical treatment, cases undergoing surgical treatment for unresectable tumor, cases undergoing non-radical resection for resectable tumor and cases undergoing radical resection for resectable tumor (χ2 =121.04, P<0.001). (5) Multimodality therapy and prognosis: of 6 159 patients, there were 541 cases(8.784%) under-going postoperative adjuvant chemotherapy and advanced chemotherapy, 76 cases(1.234%) under-going radiotherapy. There were 1 170 advanced gallbladder cancer (pathological staging ≥stage Ⅲa) patients undergoing radical resection, including 126 cases(10.769%) with post-operative adjuvant chemotherapy and 1 044 cases(89.231%) without postoperative adjuvant chemo-therapy. There was no significant difference in the overall survival between cases with post-operative adjuvant chemotherapy and cases without postoperative adjuvant chemotherapy (χ2 =0.23, P=0.629). There were 658 patients with pathological staging as stage Ⅲ a who underwent radical resection, including 66 cases(10.030%) with postoperative adjuvant chemotherapy and 592 cases(89.970%) without postoperative adjuvant chemotherapy. There was no significant difference in the overall survival between cases with postoperative adjuvant chemotherapy and cases without postoperative adjuvant chemotherapy (χ2 =0.05, P=0.817). There were 512 patients with pathological staging ≥stage Ⅲb who underwent radical resection, including 60 cases(11.719%) with postoperative adjuvant chemotherapy and 452 cases(88.281%) without postoperative adjuvant chemotherapy. There was no significant difference in the overall survival between cases with postoperative adjuvant chemo-therapy and cases without postoperative adjuvant chemo-therapy (χ2 =1.50, P=0.220). Conclusions There are more women than men with gallbladder cancer in China and more than half of patients are diagnosed at the age of 56 to 75 years. Cases undergoing ultrasound, CT, serum CA19-9 examination before initial diagnosis are independent influencing factors influencing initial diagnosis of gallbladder cancer patients. Preoperative resectability evaluation can improve the therapy strategy and patient prognosis. Adjuvant chemotherapy for gallbladder cancer is not standardized and in low proportion in China.

  • Related Articles

    [1]Shen Yingmo, Liu Xiaoli, Zheng Ruotong, Tong Deyu, Ma Qiuyue. Research progress on epidemiology of inguinal hernia[J]. Chinese Journal of Digestive Surgery, 2024, 23(9): 1168-1172. DOI: 10.3760/cma.j.cn115610-20240802-00370
    [2]Li Shuangxi, Cai Hongzhen, Wang Qi, Wu Zhouqiao, Shan Fei, Li Ziyu, Ji Jiafu. Influencing factors for postoperative abdominal infection in gastric cancer and prognosis analysis: a report of 1 129 cases[J]. Chinese Journal of Digestive Surgery, 2024, 23(3): 380-385. DOI: 10.3760/cma.j.cn115610-20240124-00037
    [3]Ni Kunhan, Li Changding, Jiang Longlin, He Wenwu, Wang Chenghao, Wang Kangning, Liu Guangyuan, Peng Lin, Fang Qiang, Xiao Wenguang, Qiao Liang, Wang Qifeng, Han Yongtao, Leng Xuefeng. Surgical treatment and prognosis analysis of thoracic esophageal squamous cell carcinoma: a report of 2 766 cases[J]. Chinese Journal of Digestive Surgery, 2023, 22(10): 1199-1204. DOI: 10.3760/cma.j.cn115610-20230927-00120
    [4]Ma Yifei, He Hairong, Yan Tian'ao, Ding Jiachun, Zhu Ze'en, Wu Zheng, Ma Qingyong, Wang Zheng. Epidemiological trends and major risk attribution analysis of pancreatic cancer in China, Japan and South Korea from 1990 to 2019[J]. Chinese Journal of Digestive Surgery, 2022, 21(4): 507-519. DOI: 10.3760/cma.j.cn115610-20220310-00126
    [5]Analysis and prediction of the epidemiological trend of liver cancer in the Chinese population from 1990 to 2019[J]. Chinese Journal of Digestive Surgery, 2022, 21(1): 106-113. DOI: 10.3760/cma.j.cn115610-20211203-00616
    [6]Qin Changfu, Chen Jie, Shen Yingmo, Cheng Lili, Li Guangxing. Treatment analysis and epidemiological study on external abdominal hernia based on the Hernia Registry in China[J]. Chinese Journal of Digestive Surgery, 2021, 20(7): 785-789. DOI: 10.3760/cma.j.cn115610-20210616-00282
    [7]Epidemiological trend analysis of gastric cancer in China from 2000 to 2019 [J]. Chinese Journal of Digestive Surgery, 2021, 20(1): 102-109. DOI: 10.3760/cma.j.cn115610-20201130-00746
    [8]Lyu Wencai1, Zou Yun1, Wen Shuang2, Jia Li3, Fu Weili1, Geng Xiaoping4. Analysis of the incidence and epidemic trend of gallbladder cancer in China[J]. Chinese Journal of Digestive Surgery, 2019, 18(2): 186-189. DOI: 10.3760/cma.j.issn.1673-9752.2019.02.015
    [9]Gong Peng, Liu Peng, Zhang Xianbin, Geng Zhimin, Zhai Wenlong, Qiu Yinghe, Song Tianqiang, He Yu, Li Jingdong, Li Shengping, Tang Zhaohui.. Diagnosis and treatment of unexpected gallbladder carcinoma: a multicenter retrospective study (A report of 223 cases)[J]. Chinese Journal of Digestive Surgery, 2018, 17(3): 252-256. DOI: 10.3760/cma.j.issn.1673-9752.2018.03.008
    [10]DONG Na na, DUAN Xiao feng, ZHANG Ti, LI Hui kai, ZHOU Hong yuan, NIU Guangcai, SHEN Changming, LI Qiang. Analysis of treatment and prognosis of primary gallbladder cancer[J]. Chinese Journal of Digestive Surgery, 2012, 11(3): 267-270. DOI: 10.3760/cma.j.issn.1673-9752.2012.03.020

Catalog

    Article views (1793) PDF downloads (0) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return